Newsletter

Autoimmune Disease

Random
A glass of water standing near a collection of pills.

Gilead: Positive Phase 2b/3 Trial Data of Filgotinib for Ulcerative Colitis

Transmission electron micrograph of SARS-CoV-2 virus particles.

COVID-19: Implications for Ulcerative Colitis and Crohn’s Disease Patients

A paper readout from a diagnostic machine.

Navidea: Positive Data in Phase 2B Trial of Tilmanocept Imaging

Regulatory T cells control fibroblast activation in skin to suppress fibrosis

Survey Reveals Ulcerative Colitis Patients’ Treatment Goals

CD and UC Patients Distinguished by Mesenteric Lymph Node Microbiome

Oxidative stress innate immune cell atlas in neuroinflammation discovered by Tox-seq.

Researchers Profile Immune Cells Implicated in Neurodegenerative Diseases

Entyvio pen and injector for subcutaneous administration.

Entyvio SC Approved in Europe as Maintenance Therapy for UC and...

A man holding a syringe and a vial of medication.

Dupilumab for Eosinophilic Esophagitis: “Pivotal Data” in Phase 3 Trial

Red, white, and yellow pills resting on a pink surface.

JAK1 Inhibitor Filgotinib Shows Efficacy in Treatment of Psoriatic Arthritis

12Page 1 of 2

Contact

Connect

Follow Us

ImmunoFrontiers © 2019-2021. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

error: Content is protected.